MDM2 and acute myeloid leukemia: MDM2 rs2279744 variant was associated with secondary AML type and changes in PLT count and MDM2 rs3730485 with secondary (hepatic, renal, cardiac, pulmonary, gastro-intestinal, dermatological) events as a result of treatment toxicity.